Fundraise

Brazil's dr.consulta raises $30M from IFC to widen healthcare access

What's the deal? São Paulo-based dr.consulta has raised $30 million (US$39.7M) in a late-stage round led by the International Finance Corporation (IFC), the World Bank GroupDealroom has a profile for this one. Try Dealroom →'s investment arm. The deal buys a minority stake in the medical-centre network, though dr.consulta has not disclosed the size of that stake.

Where the money goes: The company will fund geographic expansion, technology platforms, and clinical capacity. Its target is to serve 10 million Brazilians by 2030 — more than double the four million it has treated since 2011.

What it does: Founded in 2011 to widen access to private care for people without traditional health plans, dr.consulta runs owned clinics backed by proprietary technology and data integration, plus an AI assistant called Veri that supports patients over WhatsApp. It now performs about 1.5 million consultations a year with roughly 1,500 health professionals.

Why now? The round follows a turnaround cycle begun after its previous raise, led by PatriaDealroom has a profile for this one. Try Dealroom →, LightrockDealroom has a profile for this one. Try Dealroom →, IDBDealroom has a profile for this one. Try Dealroom →, and JICADealroom has a profile for this one. Try Dealroom →, which brought a new executive team and changes to the operating model. "This investment validates our trajectory and our commitment to broadening access to quality healthcare for millions of Brazilians," said chief executive officer Massanori Shibata Jr.

The expansion play: Earlier in 2026, dr.consulta announced a US$10.2M plan to open five units in Rio de Janeiro, its renewed push beyond São Paulo. The first opened in Tijuca inside a Supermercado Guanabara branch, part of a strategy to place care where consumers already shop; the company projected 150,000 patients in its first year there.

The signal: A development-finance backer taking a stake signals confidence in scaling low-cost private healthcare across Brazil, where the model targets patients underserved by traditional plans. The size of the round places it among the larger late-stage healthcare deals in the market.

Read more: exame.com

Image credit: Dr. consulta

More top stories